KCNQ2 and amyotrophic lateral sclerosis: Ezogabine activates voltage-gated potassium channels, which could counteract the reduction in mRNA expression of KCNQ2 (Kv7.2 channel) observed in spinal motor neurons in ALS patient, as mentioned previously [96].